News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
Presentation VIVA 2017 What is the Right Antiplatelet Therapy for Symptomatic Carotid Disease? Presenter: William Gray September 21, 2017
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Daily News Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis Michael O'Riordan June 09, 2017
News Conference News EAS 2017 Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive Yael L. Maxwell May 01, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News E-Cigarettes May Increase CV Disease Risk Just Like the Real Thing L.A. McKeown February 03, 2017